| Bristol-Myers Squibb Company (BMY) | |||
|---|---|---|---|
| 46.58 -1.28 (-2.67%) | 08-23 16:01 | ||
| Open: | 47.77 | Pre. Close: | 47.86 |
| High: | 48.195 | Low: | 46.285 |
| Volume: | 16,321,221 | Market Cap: | 76194M |
| Price Prediction (Update @5:00pm) | ||
|---|---|---|
| If tomorrow: | Open lower | Open higher |
| High: | 48.229 - 48.473 | 48.473 - 48.629 |
| Low: | 45.708 - 46.026 | 46.026 - 46.229 |
| Close: | 46.124 - 46.604 | 46.604 - 46.911 |
| Stock Technical Analysis | |
|---|---|
| Overall: |   |
| Target: | Six months: 56.33 One year: 65.80 |
| Support: | Support1: 44.68 Support2: 42.48 |
| Resistance: | Resistance1: 48.23 Resistance2: 56.33 |
| Pivot: | 46.71  |
| Moving Averages: | MA(5): 47.46 MA(20): 46.31 MA(100): 46.19 MA(250): 50.41 |
| MACD: | MACD(12,26): 0.54 Signal(12,26,9): 0.42 |
| %K %D: | %K(14,3): 77.56 %D(3): 87.49 |
| RSI: | RSI(14): 52.25 |
| 52-Week: | High: 63.69 Low: 42.48 Change(%): -22.3 |
| Average Vol(K): | 3-Month: 1313029 10-Days: 953798 |
| Price, MAs and Bollinger Bands |
|---|
| Price and moving averages has closed below its Short term moving average. Short term moving average is currently above mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and NEUTRAL in mid-long term.BMY has closed above bottom band by 46.1%. Bollinger Bands are 10.9% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices. |
| Stock chart |
|---|
 |
| Stock News |
|---|
|
Sat, 24 Aug 2019 16:12:10 Z Why Is Bristol-Myers (BMY) Up 2.6% Since Last Earnings Report? Fri, 23 Aug 2019 23:08:46 Z Will Lawsuits Sink Johnson & Johnson Stock? Fri, 23 Aug 2019 22:10:37 Z 5 Healthcare Stocks to Buy for Healthy Dividends Fri, 23 Aug 2019 14:19:10 Z Retrophin Down on Neurological Disorder Drug Study Failure Fri, 23 Aug 2019 14:18:03 Z Roche's Tecentriq Gets Japan's Nod for Small Cell Lung Cancer |
| Financial Analysis | |
|---|---|
| Growth |  |
| Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing. | |
| Profitability | |
| Profitability measures a company's ability to generate earnings as compared to its expenses and other relevant costs. | |
| Solvency | |
| Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry. | |
| Efficiency |  |
| Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not. | |
| Stock Basics & Statistics | |
|---|---|
| Sector: Healthcare | |
| Industry: Drug Manufacturers - Major | |
| Shares Out. (M) | 1630.00 |
| Shares Float (M) | 1630.00 |
| % Held by Insiders | 0.11 |
| % Held by Institutions | 75.05 |
| Shares Short (K) | 111320 |
| Shares Short Prior Month (K) | |
| Stock Financials | |
|---|---|
| EPS | 3.800 |
| EPS Est. Current Year | 3.000 |
| EPS Est. Next Year | 3.230 |
| EPS Est. Next Quarter | 0.790 |
| Forward EPS | 3.720 |
| Book Value (p.s.) | 9.810 |
| PEG Ratio | 2.42 |
| Profit Margin | 26.00 |
| Operating Margin | 29.59 |
| Return on Assets (ttm) | 10.1 |
| Return on Equity (ttm) | 43.6 |
| Qtrly Rev. Growth | 10.0 |
| Gross Profit (p.s.) | 9.859 |
| Sales Per Share | |
| EBITDA (p.s.) | 4.693 |
| Qtrly Earnings Growth | 283.90 |
| Operating Cash Flow (M) | 7180.00 |
| Levered Free Cash Flow (M) | 4290.00 |
| Stock Valuation | |
|---|---|
| P/E | 12.26 |
| P/E Growth Ratio | -0.03 |
| P/BV | 4.75 |
| P/S | 5200369664.00 |
| P/CF | 10.57 |
| Dividend Yield | 0.03 |
| Dividends & Splits | |
|---|---|
| Dividend | 1.630 |
| Dividend Pay Date | 2019-08-01 |
| Ex-Dividend Date | 2019-07-03 |
| Forward Dividend | 1.640 |
| Last Split Date | |
| Last Split Ratio | -1e+010 |
